Ertapenem Sodium

6 trials 4 recruiting JAnti-infectives

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

4 Recruiting

1 Completed trials

6 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 4

Indications tested

Antibiotic level therapeutic 1 Bacterial infection 1

Sponsors using this IMP

Azienda Ospedaliero Universitaria Di Modena 1 Centre Hospitalier Universitaire De Nantes 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Hvidovre Hospital 1 Region Hovedstaden 1 Uppsala Universitet 1

All trials

6 total

Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Intravenous Fosfomycin in hospitalized patients with complicated urinary tract infections due to Third-generation cephalosporinresistant Ent… Recruiting

2024-516591-15-00 Phase IV 1 country Azienda Ospedaliero Universitaria Di Modena
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study Recruiting

2024-514900-16-00 Phase IV 1 country Region Hovedstaden
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Phase III 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…

Showing 1–6 of 6 trials

← All drugs A–Z